Ann: Quarterly Activity Report & Appendix 4C, page-2

I think you're right @Pledge  ... this mob seem to have no idea how much trials cost to run - let alone global trials


"$12.1 million to last until H2 2025" .... good luck with that estimate if the 30 cent oppies aren't exercised by then ..... running on the smell of an oily rag as they say  .... this paragraph in the GVHD trial section screams expenditure to me ... CR by 30 June 2024 me thinks


"Cynata expects to open multiple additional clinical centres by the end of the 2023 calendar year, in both the USA and Australia. The Company is also seeking approval to commence the trial in a number of European countries, and is continuing to progress the regulatory process in those jurisdictions."